Stocks to Watch: ASCO -continued-INCY, ONXX, SUPG
This is a continuation of pre-ASCO coverage, reviewing companies that will have significant clinical presentations on cancer products in their pipeline. Incyte Corporation (INCY $17.82) up 1.94%. is focused on small molecule drugs for hematological and oncology applications and for chronic autoimmune and inflammatory diseases.In oncology the Company has four indications for its JAK inhibitor [...]
